Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Immunity & Ageing
Published in: Immunity & Ageing 1/2010

Open Access 01-12-2010 | Short report

Characterization of leukotrienes in a pilot study of older asthma subjects

Authors: Sharmilee M Nyenhuis, Elizabeth A Schwantes, Sameer K Mathur

Published in: Immunity & Ageing | Issue 1/2010

Login to get access

Excerpt

Asthma is a chronic inflammatory disorder of the lower airway that results in mucus secretion, airway edema and reversible airway obstruction [1]. These characteristic features lead to the clinical symptoms of asthma, which include recurrent episodes of wheezing, breathlessness, chest tightness and coughing [2]. The pathophysiology of asthma is not fully elucidated but the current paradigm involves multiple cell types (ie. eosinophils, neutrophils, mast cells, T-cells) and their mediators. …
Appendix
Available only for authorised users
Literature
1.
2.
Busse W, Kraft M: Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest. 2005, 127 (4): 1312-26. 10.1378/chest.127.4.1312.CrossRefPubMed
3.
Enright PL: Underdiagnosis and Undertreatment of Asthma in the Elderly. Chest. 1999, 116 (3): 603-613. 10.1378/chest.116.3.603.CrossRefPubMed
4.
Bellia V: Asthma in the elderly - Mortality rate and associated risk factors for mortality. Chest. 2007, 132 (4): 1175-1182. 10.1378/chest.06-2824.CrossRefPubMed
5.
Quadrelli SA, Roncoroni AM: Features of asthma in the elderly. Journal of Asthma. 2001, 38 (5): 377-389. 10.1081/JAS-100000259.CrossRefPubMed
6.
Marks GB, Correll PK, Williamson M: Asthma in Australia 2005. Medical Journal of Australia. 2005, 183 (9): 445-446.PubMed
7.
Banerji A: Prospective multicenter study of acute asthma in younger versus older adults presenting to the emergency department. Journal of the American Geriatrics Society. 2006, 54 (1): 48-55. 10.1111/j.1532-5415.2005.00563.x.CrossRefPubMed
8.
Oguzulgen IK: What can predict the exacerbation severity in asthma?. Allergy and Asthma Proceedings. 2007, 28 (3): 344-347. 10.2500/aap.2007.28.2949.CrossRefPubMed
9.
Moorman JERR, Johnson CA: National Surveillance for Asthma --- United States, 1980--2004. MMWR Surveillance Summary. 2007, 56 (8): 1-54.
10.
Busse WW: Leukotrienes and inflammation. American Journal of Respiratory and Critical Care Medicine. 1998, 157 (6): S210-S213.CrossRef
11.
Nagata M, Sedgwick JB, Busse WW: Differential-Effects of Granulocyte-Macrophage Colony-Stimulating Factor on Eosinophil and Neutrophil Superoxide Anion Generation. Journal of Immunology. 1995, 155 (10): 4948-4954.
12.
Hamid Q: Inflammatory cells in asthma: Mechanisms and implications for therapy. Journal of Allergy and Clinical Immunology. 2003, 111 (1, Supplement 1): S5-S17. 10.1067/mai.2003.22.CrossRefPubMed
13.
Pavord ID: Induced Sputum Eicosanoid Concentrations in Asthma. Am J Respir Crit Care Med. 1999, 160 (6): 1905-1909.CrossRefPubMed
14.
15.
Gern JE: Relationship of Upper and Lower Airway Cytokines to Outcome of Experimental Rhinovirus Infection. American Journal of Respiratory and Critical Care Medicine. 2000, 162 (6): 2226-2231.CrossRefPubMed
16.
Yamamoto H, Sedgwick JB, Busse WW: Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. Journal of Immunology. 1998, 161 (2): 971-977.
17.
Sears MR: A Longitudinal, Population-Based, Cohort Study of Childhood Asthma Followed to Adulthood. The New England Journal of Medicine. 2003, 349 (15): 1414-1422. 10.1056/NEJMoa022363.CrossRefPubMed
18.
Nyenhuis SM: Airway neutrophil inflammatory phenotype in older subjects with asthma. The Journal of allergy and clinical immunology. 125 (5): 1163-1165. 10.1016/j.jaci.2010.02.015.
19.
Fulop T: Signal transduction and functional changes in neutrophils with aging. Aging Cell. 2004, 3 (4): 217-226. 10.1111/j.1474-9728.2004.00110.x.CrossRefPubMed
20.
Fortin CF: GM-CSF activates the Jak/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals. Biogerontology. 2007, 8 (2): 173-187. 10.1007/s10522-006-9067-1.CrossRefPubMed
21.
Wenzel SE: The role of leukotrienes in asthma. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2003, 69 (2-3): 145-155. 10.1016/S0952-3278(03)00075-9.CrossRef
22.
Schleimer RP: An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. Journal of Pharmacology And Experimental Therapeutics. 1989, 250 (2): 598-605.PubMed
23.
Steiss JO: Effect of inhaled corticosteroid treatment on exhaled breath condensate leukotriene E-4 in children with mild asthma. Allergy and Asthma Proceedings. 2008, 29 (4): 371-375. 10.2500/aap.2008.29.3135.CrossRefPubMed
24.
Creticos P: Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age. Annals of Allergy Asthma & Immunology. 2002, 88 (4): 401-409.CrossRef
25.
Korenblat PE: Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Annals of Allergy Asthma & Immunology. 2000, 84 (2): 217-225.CrossRef
26.
Wenzel SE: Asthma: defining of the persistent adult phenotypes. The Lancet. 2006, 368 (9537): 804-813. 10.1016/S0140-6736(06)69290-8.CrossRef
Metadata
Title
Characterization of leukotrienes in a pilot study of older asthma subjects
Authors
Sharmilee M Nyenhuis
Elizabeth A Schwantes
Sameer K Mathur
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2010
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/1742-4933-7-8

Other articles of this Issue 1/2010

Immunity & Ageing 1/2010 Go to the issue

Short report

Age-related changes in plasma levels of BDNF in Down syndrome patients

Research

Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects

Research

The effect of ageing on human lymphocyte subsets: comparison of males and females

Commentary

Immunosenescence and Cytomegalovirus: where do we stand after a decade?

Review

BELFAST nonagenarians: nature or nurture? Immunological, cardiovascular and genetic factors

Research

Differential impact of ageing on cellular and humoral immunity to a persistent murine γ-herpesvirus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits